Imgatuzumab

DB14884Investigational

Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With...

Mechanism: Pharmacologically active on Epidermal growth factor receptor and Low affinity immunoglobulin gamma Fc region receptor III-A
Curator reviewed
Code names: RO5083945

Resolves to

Compound

UNIIV77J4WJF9ZCAS959963-46-3

Targets

P00533EGFRP08637FCGR3A

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Imgatuzumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account